KAYS
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
VRNOF
Price
$1.78
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
139 days until earnings call
Ad is loading...

KAYS vs VRNOF

Header iconKAYS vs VRNOF Comparison
Open Charts KAYS vs VRNOFBanner chart's image
Kaya Holdings
Price$0.03
Change-$0.00 (-0.00%)
Volume$350
CapitalizationN/A
Verano Holdings
Price$1.78
Change-$0.00 (-0.00%)
Volume$590.11K
CapitalizationN/A
KAYS vs VRNOF Comparison Chart
Loading...
View a ticker or compare two or three
VS
KAYS vs. VRNOF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KAYS is a Hold and VRNOF is a Sell.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (KAYS: $0.03 vs. VRNOF: $1.78)
Brand notoriety: KAYS and VRNOF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KAYS: 7% vs. VRNOF: 100%
Market capitalization -- KAYS: $1.24M vs. VRNOF: $1.01B
KAYS [@Pharmaceuticals: Other] is valued at $1.24M. VRNOF’s [@Pharmaceuticals: Other] market capitalization is $1.01B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KAYS’s FA Score shows that 1 FA rating(s) are green whileVRNOF’s FA Score has 1 green FA rating(s).

  • KAYS’s FA Score: 1 green, 4 red.
  • VRNOF’s FA Score: 1 green, 4 red.
According to our system of comparison, KAYS is a better buy in the long-term than VRNOF.

Price Growth

KAYS (@Pharmaceuticals: Other) experienced а -20.00% price change this week, while VRNOF (@Pharmaceuticals: Other) price change was -12.75% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.99%. For the same industry, the average monthly price growth was -7.80%, and the average quarterly price growth was -7.77%.

Reported Earning Dates

KAYS is expected to report earnings on Apr 27, 2023.

VRNOF is expected to report earnings on Apr 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.99% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
VRNOF($1.01B) has a higher market cap than KAYS($1.24M). VRNOF has higher P/E ratio than KAYS: VRNOF (93.46) vs KAYS (0.70). KAYS YTD gains are higher at: -23.990 vs. VRNOF (-60.268). VRNOF has higher annual earnings (EBITDA): 36.4M vs. KAYS (-1.42M). VRNOF has more cash in the bank: 95.1M vs. KAYS (30.5K). KAYS has less debt than VRNOF: KAYS (7.66M) vs VRNOF (502M). VRNOF has higher revenues than KAYS: VRNOF (904M) vs KAYS (545K).
KAYSVRNOFKAYS / VRNOF
Capitalization1.24M1.01B0%
EBITDA-1.42M36.4M-4%
Gain YTD-23.990-60.26840%
P/E Ratio0.7093.461%
Revenue545K904M0%
Total Cash30.5K95.1M0%
Total Debt7.66M502M2%
FUNDAMENTALS RATINGS
KAYS: Fundamental Ratings
KAYS
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

KAYS and

Correlation & Price change

A.I.dvisor tells us that KAYS and KMDA have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KAYS and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAYS
1D Price
Change %
KAYS100%
-13.98%
KMDA - KAYS
20%
Poorly correlated
-2.82%
AYRWF - KAYS
6%
Poorly correlated
-9.30%
UPC - KAYS
5%
Poorly correlated
-17.30%
VRNOF - KAYS
3%
Poorly correlated
-7.29%
KKPCF - KAYS
2%
Poorly correlated
N/A
More

VRNOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRNOF has been closely correlated with GTBIF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if VRNOF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRNOF
1D Price
Change %
VRNOF100%
-7.29%
GTBIF - VRNOF
79%
Closely correlated
-4.21%
CURLF - VRNOF
77%
Closely correlated
-1.79%
TCNNF - VRNOF
76%
Closely correlated
-6.28%
TSNDF - VRNOF
73%
Closely correlated
-2.00%
CRLBF - VRNOF
72%
Closely correlated
-2.78%
More